Supernus Pharmaceuticals, Inc.
SUPN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001356576
No open-market purchases or sales by Supernus Pharmaceuticals, Inc. insiders were filed in the last 90 days; 334 institutions reported holding it in 13F filings for Q2 2026, worth $2.80B in total; no superinvestor holds it.
13F holders, Q4 2024
Institutional positions in Supernus Pharmaceuticals, Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 294
- +22 vs. Q3 2024
- Shares held
- 59.5M
- −172.5K (−0.3%) vs. Q3 2024
- Total value
- $2.15B
- +$291.6M (+15.7%) vs. Q3 2024
- New holders
- 42
- 102 more added
- Sold out
- 20
- 98 more reduced
1 institution that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SUPN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 334 | $2.80B |
| Q1 2026 | 328 | $3.01B |
| Q4 2025 | 333 | $2.84B |
| Q3 2025 | 310 | $2.76B |
| Q2 2025 | 295 | $1.87B |
| Q1 2025 | 295 | $1.94B |
| Q4 2024 | 294 | $2.15B |
| Q3 2024 | 273 | $1.87B |
| Q2 2024 | 245 | $1.56B |
| Q1 2024 | 251 | $1.93B |
| Q4 2023 | 245 | $1.65B |
| Q3 2023 | 239 | $1.57B |
| Q2 2023 | 249 | $1.72B |
| Q1 2023 | 259 | $2.01B |
| Q4 2022 | 264 | $1.99B |
| Q3 2022 | 244 | $1.88B |
| Q2 2022 | 225 | $1.58B |
| Q1 2022 | 230 | $1.75B |
| Q4 2021 | 235 | $1.61B |
| Q3 2021 | 224 | $1.45B |
| Q2 2021 | 226 | $1.67B |
| Q1 2021 | 224 | $1.40B |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Supernus Pharmaceuticals, Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Dynamic Technology Lab Private Ltd | 0 | $0 | 0.00% | −11,288−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −8,184−100.0% | Sold out |
| Rafferty Asset Management, LLC | 0 | $0 | 0.00% | −7,570−100.0% | Sold out |
| Campbell & CO Investment Adviser LLC | 0 | $0 | 0.00% | −6,470−100.0% | Sold out |
| Corton Capital Inc. | 0 | $0 | 0.00% | −6,467−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −1,026−100.0% | Sold out |
| Catalyst Funds Management Pty Ltd | 0 | $0 | 0.00% | −800−100.0% | Sold out |
| International Assets Investment Management, LLC | 0 | $0 | 0.00% | −686−100.0% | Sold out |
| Point72 (DIFC) Ltd | 0 | $0 | 0.00% | −455−100.0% | Sold out |
| Capital Performance Advisors LLP | 0 | $0 | 0.00% | −29−100.0% | Sold out |
| Ronald Blue Trust, Inc. | 0 | $0 | 0.00% | −24−100.0% | Sold out |
| CVA Family Office, LLC | 0 | $0 | 0.00% | −14−100.0% | Sold out |
| Mendota Financial Group, LLC | 0 | $0 | 0.00% | −5−100.0% | Sold out |
| Claris Advisors, LLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Scout Investments, Inc. | – | – | – | – | Not filed |